A sham-controlled randomized trial demonstrated that pulsed field ablation (PFA) markedly reduced atrial fibrillation (AF) recurrence and burden while significantly improving quality of life and psychological distress compared with a sham procedure in highly symptomatic AF patients. In this single-blind study, 60 patients with severe AF-related quality-of-life impairment were randomized to either PFA or a sham procedure and followed with continuous rhythm monitoring using implantable cardiac monitors. After 6 months, AF recurrence occurred in only 6.7% of patients treated with PFA versus 83.3% in the sham group. Quality-of-life scores improved dramatically with PFA, increasing by nearly 44 points compared with 11 points in the sham group. AF burden was also substantially lower after PFA, and patients experienced significantly greater reductions in anxiety and depression symptoms. These findings provide strong evidence that the clinical and psychological benefits of AF ablation extend well beyond placebo effects, confirming PFA as an effective treatment for symptomatic AF. Source: https://www.ahajournals.org/
A secondary MRI analysis of the US POINTER randomized clinical trial found that a structured…
Dementia risk factors vary substantially across countries, but they frequently cluster together in similar patterns…
A systematic review and network meta-analysis of 262 randomized trials involving 99,791 participants found that…
Approximately 21% of patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events…
A Danish randomized crossover trial found that a single session of high-intensity interval exercise (HIIE)…
Baseline use of proton pump inhibitors (PPIs) and, to a lesser extent, antibiotics was associated…
This website uses cookies.